New Study: Immunodiagnostics Market is expanding at $17,836 Million by 2022 and expected to increase with rapid CAGR growth, says AMR

Global Immunodiagnostics Market is expected to reach $17,836 Million by 2022, growing at a CAGR of 7.3% from 2016 to 2022, accordingly new report published by Allied Market Research.

Immunodiagnostics is the branch of in vitro diagnostics that deals with the diagnosis of several diseases on the basis of antigen antibody reaction. Its a primary means for diagnosing infectious disease, chronic diseases such as cancer and cardiovascular diseases, autoimmunity diseases, and endocrinology among others. The significant advancement in the immunodiagnostics technologies have enhanced the ability to target the areas to diagnose disease progression. The growth in development has improved the diagnosis of complex diseases.

The immunodiagnostics market is segmented based on product type into reagents, instruments, and software & services. The infectious diseases holds a remarkable share in the global immunodiagnostics market and is expected to maintain its lead during the study period. This is attributed by the growth in preference of automated and next generation immunodiagnostics platform due to accurate, rapid and reliable outcomes and increased adoption by the clinicians.

Download Sample Report @ https://www.alliedmarketresearch.com/request-sample/1763?utm_source=opr_sank

Infectious diseases (such as hepatitis, retrovirus, HIV, dengue fever, malaria, and others) is a leading segment in the immunodiagnostics application market accounted for over one-fifth of total share in 2015. Owing to diversified use of immunodiagnostics devices in the diagnosis of varied infectious diseases with lower risk followed by quick, reliable, and high success rate has favored its growth in infectious diseases market.

Chemiluminescence Immunoassays (CLIA) is expected to grow at the fastest rate, owing to their associated benefits such as improved outcome in terms of quantification at low concentration of samples from complex mixture, non-radioactive nature, and high accuracy and sensitivity in detection of analytes in the test sample. Rapid tests is expected to grow at a CAGR of 7.5%, owing to technological advancements in the segment.

Clinical laboratories would maintain its lead in the overall immunodiagnostics market throughout the analysis period, primarily due to the growth in number of immunodiagnostics laboratories equipped with technologically advanced devices in the developed economies. Although, the chronic diseases and infectious diseases are prevalent in developing economies as well, however due to the low awareness, less initiative for preventive care and unmet medical needs at economical cost has restricted the market growth in these areas.

On the other hand, the growth in demand of immunodiagnostics products in developed economies such as North America and Europe have further boosted the market growth due to the high incidence rate of complex diseases such as cancer and cardiovascular diseases, rapidly increasing ageing population, and rapid development in cancer and cardiac markers, which aids in quick diagnosis using antigen-antibody reaction. Furthermore, academics and research centers is anticipated to exhibit the highest growth, with a CAGR of 8.7% during the forecast period. This is owing to the rise in need for drug monitoring and high investment for research and development.

Key Findings of Immunodiagnostics Market:

• In 2015, reagents and consumables was the leading product type, and is projected to grow at a CAGR of 8.1% during the forecast period.
• CLIA is expected to grow at a remarkable CAGR of 8.0%, owing to the non-radioactive nature, high sensitivity, and simple equipment designed for well-equipped clinical laboratories.
• Oncology & endocrinology application is projected to grow at a high CAGR of 8.1% during the analysis period.
• U.S. alone contributes over three-fourth market share in the North America region of immunodiagnostics market in 2015.
• China is the major shareholder in the Asia-Pacific region accounting for around one-third of the Asia-Pacific immunodiagnostics market.
• North America is expected to dominate the immunodiagnostics market followed by Europe, during the analysis period.

North America accounted for the major share in the immunodiagnostics market in 2015, and is expected to maintain this trend throughout the forecast period. This is mainly due to the rise in prevalence of chronic diseases coupled with increase in geriatric population, high adoption rate of technologically advanced immunodiagnostics devices, and high awareness regarding the benefits of next generation immunodiagnostics platform. In addition, presence of highly sophisticated healthcare infrastructure, rise in measures for preventive healthcare, and favorable reimbursement scenario has propelled the market growth. However, Asia-Pacific region is anticipated to grow rapidly during the analysis period attributed to the presence of ample growth opportunities in terms of unmet medical needs for the diagnosis of infectious and chronic diseases in this region and quest for improved quality of life in emerging countries.

Product launch and acquisition were the key strategies followed by the leading companies to strengthen their market positions. Some of the key companies profiled in the report are Abbott Laboratories, Immunodiagnostic Systems Holdings Plc (IDS), DiaSorin S.p.A., Johnson & Johnson, F. Hoffmann-La Roche Ltd, Siemens AG, Sysmex Corporation , Danaher Corporation , Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., and Arkray, Inc..

Flat 20% Discount on All License Type.. https://www.alliedmarketresearch.com/checkout/917540
*Offer Valid Till 20th April 2019

About us

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client's insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com

This release was published on openPR.